SCARPA, MAURIZIO

SCARPA, MAURIZIO  

Dipartimento di Salute della Donna e del Bambino - SDB  

Mostra records
Risultati 1 - 20 di 166 (tempo di esecuzione: 0.046 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
The European reference network for metabolic diseases (MetabERN) clinical pathway recommendations for Pompe disease (acid maltase deficiency, glycogen storage disease type II) 2024 Gragnaniello V.Scarpa M.Burlina A. + ORPHANET JOURNAL OF RARE DISEASES - -
Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results (Orphanet Journal of Rare Diseases, (2022), 17, 1, (437), 10.1186/s13023-022-02587-0) 2023 Scarpa M. + ORPHANET JOURNAL OF RARE DISEASES - -
Towards the international interoperability of clinical research networks for rare diseases: recommendations from the IRDiRC Task Force 2023 Scarpa M. + ORPHANET JOURNAL OF RARE DISEASES - -
A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: One-year results 2022 Scarpa M. + GENETICS IN MEDICINE - -
Erratum: One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency (Genetics in Medicine (2021) 23(8) (1543–1550), (S1098360021050620), (10.1038/s41436-021-01156-3)) 2022 Scarpa M. + GENETICS IN MEDICINE - -
Improving clinical paediatric research and learning from COVID-19: recommendations by the Conect4Children expert advice group 2022 Scarpa M. + PEDIATRIC RESEARCH - -
Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results 2022 Scarpa M. + ORPHANET JOURNAL OF RARE DISEASES - -
Newborn screening as a fully integrated system to stimulate equity in neonatal screening in Europe 2022 Scarpa M. + THE LANCET REGIONAL HEALTH. EUROPE - -
One year of COVID-19: infection rates and symptoms in patients with inherited metabolic diseases followed by MetabERN 2022 Scarpa M. + ORPHANET JOURNAL OF RARE DISEASES - -
Rare disease education in Europe and beyond: time to act 2022 Scarpa M. + ORPHANET JOURNAL OF RARE DISEASES - -
Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS) 2022 Scarpa M. + JOURNAL OF CLINICAL MEDICINE - -
The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy 2022 Scarpa M. + FRONTIERS IN PHARMACOLOGY - -
Towards Achieving Equity and Innovation in Newborn Screening across Europe 2022 Scarpa M. + INTERNATIONAL JOURNAL OF NEONATAL SCREENING - -
WORLDSymposiumTM 2022⁎: 18th Annual Research Meeting, Scientific Sessions 2022 Scarpa M. + MOLECULAR GENETICS AND METABOLISM - -
A generic emergency protocol for patients with inborn errors of metabolism causing fasting intolerance: A retrospective, single-center study and the generation of www.emergencyprotocol.net 2021 Scarpa M.Donati M. A. + JOURNAL OF INHERITED METABOLIC DISEASE - -
Acid sphingomyelinase deficiency: A clinical and immunological perspective 2021 Scarpa M. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
An international classification of inherited metabolic disorders (ICIMD) 2021 Ali H.Scarpa M.Zeviani M. + JOURNAL OF INHERITED METABOLIC DISEASE - -
Challenges in Transition From Childhood to Adulthood Care in Rare Metabolic Diseases: Results From the First Multi-Center European Survey 2021 Scarpa M. + FRONTIERS IN MEDICINE - -
European Reference Networks: challenges and opportunities 2021 Scarpa M. + JOURNAL OF COMMUNITY GENETICS - -
Focal hepatic lesions in acid sphingomyelinase deficiency: Differential diagnosis between foamy macrophages aggregates and malignancy 2021 Scarpa M. + MOLECULAR GENETICS AND METABOLISM REPORTS - -